![]() |
Volumn 7, Issue 4, 2013, Pages 497-499
|
Genetic biomarkers in cardiovascular disease
|
Author keywords
aortopathy; Brugada syndrome; cardiomyopathy; channelopathy; genetic testing; inherited cardiac conditions
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
BIOLOGICAL MARKER;
SODIUM CHANNEL NAV1.5;
TRANSFORMING GROWTH FACTOR BETA;
ANTICIPATORY GUIDANCE;
AORTA DISEASE;
BRUGADA SYNDROME;
CARDIOVASCULAR DISEASE;
CONGESTIVE CARDIOMYOPATHY;
CORONARY ARTERY DISEASE;
GENE MUTATION;
GENE SEQUENCE;
GENETIC ASSOCIATION;
GENETIC COUNSELING;
GENETIC MARKER;
GENETIC SCREENING;
HUMAN;
HYPERTROPHIC CARDIOMYOPATHY;
MARFAN SYNDROME;
MEDICAL ETHICS;
NATIONAL HEALTH SERVICE;
PATHOGENESIS;
PATHOGENICITY;
PRACTICE GUIDELINE;
PROGNOSIS;
REVIEW;
SCN5A GENE;
SIGNAL TRANSDUCTION;
SUDDEN CARDIAC DEATH;
CARDIOVASCULAR DISEASES;
GENETIC MARKERS;
GENETIC TESTING;
HUMANS;
|
EID: 84881303713
PISSN: 17520363
EISSN: 17520371
Source Type: Journal
DOI: 10.2217/bmm.13.82 Document Type: Review |
Times cited : (7)
|
References (8)
|